Clinical implications of lamivudine resistance by HBV
- 1 January 1997
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 349 (9044), 3-4
- https://doi.org/10.1016/s0140-6736(05)62154-x
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Selection of Mutations in the Hepatitis B Virus Polymerase During Therapy of Transplant Recipients With LamivudineHepatology, 1996
- A Preliminary Trial of Lamivudine for Chronic Hepatitis B InfectionNew England Journal of Medicine, 1995
- Efficacy of lamivudine on replication of hepatitis B virus in HIV-infected patientsThe Lancet, 1995
- ‘EUROHEP’ consensus report on the management of liver transplantation for hepatitis B virus infectionJournal of Hepatology, 1994